NRG-103
N/A
Report date: 2026/01/15 16:16:36
Base Information
Drug NameNRG-103
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhongnan Hospital Of Wuhan University
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesZhongnan Hospital Of Wuhan UniversityNiulunjie Biomedical Technology (Suzhou) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A